Makes sense, but I'm fairly sure that would be a February 2024 release :)
SugarSnack
joined 1 year ago
Go underarm, more biomechanically friendly
This is absolutely the way to go, but be aware that it can lead to concentration/sectoral risk when managers aren't aware of positions in the other portfolios. For example, Goldman could invest heavily in tech or pharma or whatever, not realising that JPM also have a big investment in that area.
๐